CLINICAL_TRIALS
trial_result
· 2022-05-06
Clinical Trial Update: Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy [Phase 3]
Summary
A Phase 3 trial comparing intravitreal aflibercept to laser therapy for retinopathy of prematurity has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Retinopathy of Prematurity (ROP) | Phase 3 | Status: COMPLETED | Results posted: 2022-05-06